Oaktree Weighs $300 Million Investment in Bankrupt Biotech Fund

Oaktree Capital Management is contemplating a $300 million investment in a bankrupt biotechnology fund. Bloomberg posted on X that the fund is linked to Russian billionaire Dmitry Rybolovlev’s family trust, which is aiming to close the fund. The potential investment by Oaktree could provide a lifeline to the struggling fund, which has faced significant financial challenges. Rybolovlev's family trust has been actively involved in the fund's operations, but recent developments have led to its current financial predicament. The decision by Oaktree to invest is still under consideration, and further details are expected to emerge as discussions progress.